Drugmakers push back on employer's drug pricing tactics; Bancel and Sanders spar over Moderna

Taking stock of the drug industry, from the lab to the medicine chest

March 22, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines Outside vendors are used to help patients obtain drugs for free from patient assistance programs run by drug makers or foundations. By Ed Silverman STAT+ | NIH rejects bid to cut a cancer drug's price by sidestepping patents "The decision gives pharmaceutical companies license to charge American citizens whatever price" they want, said cancer patient Robert Sachs By Ed Silverman Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government "We disagree," the Moderna chief tells the hard-charging senator in a contentious hearing about profits from the Covid-19 vaccine. By Rachel Cohrs Michael Probst/AP Opinion: The lesson biotech absolutely should not take from Silicon Valley Bank's failure The right-wing media machine's public autopsy of Silicon Valley Bank was striking in its factual and moral bankruptcy. By Paul J. Hastings STAT+ | Senators interrogate health secretary Becerra on Alzheimer's drug coverage The future of Alzheimer's treatments and coverage hung heavily over lawmakers' hearing with HHS Secretary Xavier Becerra. By Sarah Owermohle

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser